Plastic versus mitral valve replacement in ischemic mitral regurgitation

Unlike degenerative mitral insufficiency, ischemic failure is due to an increase in the left ventricular cavity, the loss of its elliptical form, ring dilation and displacement of the papillary muscles leading to the loss of coaptation the leaflets. European and American guidelines suggest the intervention on the mitral valve in patients with ischemic mitral regurgitation who will undergo coronary artery bypass graft surgery (CABG). However it is not clear whether plastic or changes it. We included 251 patients with severe ischemic mitral regurgitation randomized to plastic valve or mitral valve replacement with CABG. The primary endpoint was the left ventricular reverse degree remodeling assessed by end-systolic volume. At year’s end systolic volume was similar between both groups (54.6 ± 25 ml/m2 for plastic group versus 60.7 ± 31.5 ml/m2 for the valve replacement group, P = .18). The recurrence rate of mitral regurgitation at one year was significantly higher in the plastic group (32.6 versus 2.3%, p <0.001). 

Conclusion: 

Valve replacement in ischemic mitral regurgitation provides longer lasting effects than plastic mitral valve repair with no differences in the left ventricular reverse degree remodeling or patients clinically.

5_michael_acker
Michael Acker.
2013-11-18

Original title: Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve.

More articles by this author

VISTA 16: anti-inflammatory agent in acute coronary syndromes

There is evidence that inflammation would have an impact on the prognosis of patients experiencing acute coronary syndromes. The phospholipase A2 inhibitor Varespladib has...

TOPCAT: Spironolactone in heart failure with preserved ejection fraction

The aldosterone blockade has shown benefit in the treatment of heart failure with systolic dysfunction after stroke. The aim of this study was to...

MINERVA trial: DDDR versus DDDRP-MVP in patients with bradycardia

The sinus node disease is approximately 50 % of pacemaker implants. Atrial fibrillation is a frequent comorbidity of pacemakers and is associated with heart...

HF ROSE: Dopamine and Neseritide in heart failure associated with renal dysfunction

Previous small studies have suggested that low-dose dopamine or neseritide can enhance congestive signs of acute heart failure without altering renal function. 360 patients...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....